Finance

Rocket Lab's Q2 2026 Earnings: What to Watch on August 10

Marcus SterlingPublished 4d ago6 min readBased on 8 sources
Reading level
Rocket Lab's Q2 2026 Earnings: What to Watch on August 10
Photo by UnknownM1 / CC BY-SA 4.0

Rocket Lab USA (NASDAQ: RKLB) will release its second-quarter 2026 financial results after market close on August 10, 2026, with a conference call to follow at 5:00 PM EDT. Analysts surveyed ahead of the report are forecasting a net loss of about 3 cents per share, according to Yahoo Finance.

The company's own guidance, issued on its first-quarter call in May, points to Q2 2026 revenue between $225 million and $240 million. That range sits above the $207.5 million LSEG consensus cited at the time, suggesting management saw demand visibility well beyond what Wall Street analysts had modeled (CNBC). LSEG consensus refers to the average revenue estimate compiled by London Stock Exchange Group's data service. Rocket Lab also guided stock-based compensation to $19–$21 million for the quarter — a non-cash expense (payment in shares rather than cash) that's worth tracking against revenue to understand how much of the company's operating costs are real cash outflows versus paper charges (Rocket Lab Investor Relations).

The Q1 2026 report, released May 7, set a high bar. Revenue hit a record, up 64% year-on-year, while backlog reached $2.2 billion (Investing.com). Net loss narrowed to roughly $45 million, compared with about $60.6 million in the same quarter a year earlier (Rocket Lab Investor Relations). Backlog is the total dollar value of signed contracts the company has yet to deliver on — think of it as a pipeline of work that's been booked but not yet converted into recognized sales.

The trajectory from late 2024 into 2026 gives context for what the Q2 report needs to confirm. In Q3 2024, Rocket Lab posted revenue of $105 million, up 55% year-on-year, with backlog at $1.05 billion (Rocket Lab). Management guided Q4 2024 revenue to $125–$135 million at the time. If Q2 2026 revenue lands at the midpoint of guidance, roughly $232.5 million, that would represent approximately 72% growth from Q4 2024 levels in under two years. The backlog has more than doubled from $1.05 billion to $2.2 billion over the same period.

Separately, Rocket Lab has announced plans to acquire all outstanding shares of Iridium Communications common stock at $54 per share in a cash-and-stock transaction (Rocket Lab). The deal structure, valuation, and integration timeline are likely to feature prominently in management's prepared remarks and Q&A on the August 10 call.

The broader context here is what the Iridium acquisition means for the company's financial future. A cash-and-stock deal structure introduces dilution — the issuance of new shares that reduces existing shareholders' ownership percentage. That dilution interacts with the stock-based compensation line and the existing share count, and investors will want to hear how the acquisition affects forward revenue guidance, capital allocation, and the path to profitability.

Rocket Lab's stock rose 46% in the first half of 2026, outperforming the broader market (The Globe and Mail).

When a stock has moved that far, the market is pricing in continued growth and successful execution of strategic plans. A miss on revenue guidance, a wider-than-expected loss, or slowing backlog growth would test whether the recent valuation increase is grounded in fundamentals or driven by momentum.

The items to monitor on the call: whether Q2 revenue lands within or above the $225–$240 million guided range; the rate of net loss compression relative to the $45 million reported in Q1; any change in backlog from the $2.2 billion level; updates on the Iridium acquisition timeline and financing structure; and any revised full-year 2026 guidance. Stock-based compensation at $19–$21 million is a non-cash expense that investors should weigh against the reported loss figure to assess underlying cash burn — the actual money the company is spending each quarter.

For context, a 3-cent per share loss expectation, applied to Rocket Lab's roughly 500 million share count, implies a net loss of about $15 million for the quarter. That would be meaningful improvement from the $45 million loss in Q1. Analyst consensus on per-share losses can diverge from GAAP net income — the standard accounting measure of profit or loss — depending on share count assumptions and one-time items. The actual figure, compared against guidance and prior quarters, will be the number to watch.